Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
The Pharmacogenomics Journal|March 23, 2002
Genomic analysis of a mouse model of immunoglobulin A nephropathy reveals an enhanced PDGF-EDG5 cascadeS Katsuma, S Shiojima, A Hirasawa, et al.
British Journal of Haematology|January 29, 2000
Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study GroupA Takeshita, K Shinjo, M Higuchi, et al.
Leukemia|January 19, 2000
Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemiaT Yokozawa, M Towatari, H Iida, et al.
Experimental Hematology|May 30, 2001
Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuriaK Suenaga, Y Kanda, H Niiya, et al.
European Journal of Haematology|July 29, 2000
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemiaY Nakano, T Naoe, H Kiyoi, et al.
European Journal of Haematology|January 26, 1999
A staging system for multiple myeloma based on the morphology of myeloma cellsH Murakami, T Kawada, T Saitoh, et al.
Leukemia|February 13, 2002
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapyT Naoe, Y Tagawa, H Kiyoi, et al.
Bone Marrow Transplantation|September 14, 2004
Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working PartyI Kataoka, M Kami, S Takahashi, et al.
Blood|April 27, 1999
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemiaH Kiyoi, T Naoe, Y Nakano, et al.
Blood|June 15, 1996
Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignanciesA Hangaishi, S Ogawa, N Imamura, et al.
Pageof 22